tiprankstipranks
Trending News
More News >
Mativ Holdings, Inc. (MATV)
NYSE:MATV

Mativ Holdings (MATV) AI Stock Analysis

Compare
211 Followers

Top Page

MATV

Mativ Holdings

(NYSE:MATV)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 5.2)
,
Neutral 52 (OpenAI - 5.2)
,
Neutral 52 (OpenAI - 5.2)
,
Neutral 52 (OpenAI - 5.2)
,
Neutral 52 (OpenAI - 5.2)
Rating:52Neutral
Price Target:
$9.00
▼(-32.38% Downside)
Action:ReiteratedDate:02/20/26
The score is held back primarily by weak financial performance—especially the severe 2025 loss, negative EBITDA, and high leverage—despite supportive operating/free cash flow. Technicals are modestly constructive and the earnings call suggests operational progress and further cost savings, but ongoing demand softness and input-cost headwinds keep the risk profile elevated; valuation is mixed due to a moderate dividend but negative P/E.
Positive Factors
Strong free cash flow generation
Consistent positive operating cash flow and a record $94M free cash flow provide durable funding to pay down debt, invest in strategic projects, and support dividends or share repurchases. This cash generation reduces reliance on capital markets and cushions the firm through earnings volatility.
Sustained revenue growth and diversified end markets
Material revenue expansion into 2025, across filtration, medical/hygiene, tapes/labels and packaging, signals diversified B2B demand and repeatable sales. Broad end-market exposure and qualification barriers for specialty substrates support stable, recurring revenue over the medium term.
Margin upside from FAM outperformance and cost saves
Improved FAM margins and realized $20M in savings show structural cost and mix improvements. Additional $15–$20M of planned savings and pricing discipline can sustain margin expansion even if volumes are muted, supporting operating leverage and long-term profitability recovery.
Negative Factors
Severe 2025 loss and negative EBITDA
A large, persistent loss and negative EBITDA materially weaken earnings quality and raise the risk that operating disruptions or non-recurring charges could recur. Sustained profitability is needed to normalize metrics and restore investor and creditor confidence over the medium term.
Elevated leverage and sizable absolute debt
High gross and net leverage constrain financial flexibility and increase sensitivity to interest-rate and demand shocks. Even with strong FCF, reducing leverage to target range (2.5–3.5x) will take multiple quarters, limiting capacity for growth investments or cushioning further earnings setbacks.
Raw-material inflation and weak end-market volumes
A multi‑million raw-material headwind combined with soft volumes compresses margins and undermines operating leverage. Pricing to fully offset inflation may be constrained by end-market weakness, meaning sustained margin recovery depends on successful cost savings and mix improvement execution.

Mativ Holdings (MATV) vs. SPDR S&P 500 ETF (SPY)

Mativ Holdings Business Overview & Revenue Model

Company DescriptionMativ Holdings, Inc. operates as a performance materials company. The company operates through two segments, Advanced Materials & Structures (AMS), and Engineered Papers (EP). The AMS segment manufactures resin-based rolled goods, such as nets, films and meltblown materials, bonding products, and adhesive components, as well as adhesives and other coating solutions, and converting services. It serves healthcare, construction, industrial, transportation, and filtration end-markets. The EP segment produces various cigarette papers and reconstituted tobacco products for the tobacco industry. It also produces non-tobacco papers for various applications, such as energy storage and industrial commodity paper grades. The company sells its products in the United States, Europe and the former Commonwealth of Independent States, the Asia Pacific, the Americas, and internationally. The company was formerly known as Schweitzer-Mauduit International, Inc. and changed its name to Mativ Holdings, Inc. in July 2022. Mativ Holdings, Inc. was incorporated in 1995 and is headquartered in Alpharetta, Georgia.
How the Company Makes MoneyMativ primarily makes money by manufacturing and selling specialty materials to business customers (B2B). Revenue is generated through: (1) Sales of engineered substrates and components: The company produces nonwovens, specialty papers, and related engineered materials that are sold either as rolls/sheets or as converted components used by customers in filtration, medical/hygiene, industrial, and packaging applications. (2) Pricing tied to material inputs and value-added performance: Depending on product type and customer agreements, pricing can reflect both the underlying cost of key inputs (e.g., pulp, polymers, energy, chemicals) and the premium for engineered performance characteristics (e.g., strength, porosity, barrier properties, durability, or printability). (3) Mix of standard and customized products: Earnings are supported by ongoing supply of repeat-use materials for customers’ production runs, alongside customized or application-specific materials where performance requirements can support higher margins. (4) Volume and long-term customer relationships: Many end markets (such as filtration, tapes/labels, packaging, and medical/hygiene) require consistent supply and qualification, supporting recurring sales once products are designed into customer applications. Information about specific significant partnerships is null.

Mativ Holdings Earnings Call Summary

Earnings Call Date:Feb 18, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 13, 2026
Earnings Call Sentiment Positive
The call presents a constructive operational and financial progress narrative: management delivered record free cash flow, expanded margins and meaningful cost savings while FAM posted strong segment-level growth. However, persistent soft end-market demand (notably in SAS and Europe), expected raw material cost inflation (~$20–$25M) and a still-elevated leverage ratio (4.2x) temper the outlook. Management articulated clear levers — pricing discipline, additional cost savings ($15–$20M in 2026), inventory and capex control, and pipeline commercialization — which support confidence in continued improvement. On balance, the positives (cash generation, margin expansion, FAM momentum and realized savings) modestly outweigh the headwinds, but execution against projected savings and pricing to offset input-cost inflation will be critical.
Q4-2025 Updates
Positive Updates
Record Free Cash Flow and Cash Generation
Generated record free cash flow of $94 million in 2025, an increase of nearly 140% year-over-year, driven by operating cash flow of ~$134 million (up >40%), inventory reduction and disciplined CapEx ($40 million in 2025).
Consolidated Revenue and Organic Growth
Full year 2025 net sales were just under $2.0 billion, with organic sales up 2.5% year-over-year; Q4 net sales were $463 million, with organic sales up 1.9% versus prior year.
Adjusted EBITDA Growth and Margin Expansion
Full year adjusted EBITDA was $225 million, up 3% year-over-year. Q4 adjusted EBITDA was $53.5 million, up 19% YoY, and consolidated adjusted EBITDA margin expanded by 180 basis points versus prior year.
Filtration & Advanced Materials (FAM) Outperformance
FAM Q4 net sales of $177 million were up >5% YoY. FAM adjusted EBITDA rose to $33 million, up 26% YoY, with margins improving to 18.7% (up 300 basis points), led by favorable price-to-input-cost and mix.
Operational and Cost Savings Progress
Realized nearly $20 million of cost savings in 2025 from expense controls and efficiency initiatives; management expects an additional $15–$20 million of realized savings in 2026 (Wave 2).
Balance Sheet Improvements and Debt Reduction
Net debt reduced by over $60 million to $934 million; available liquidity of $515 million at year-end. Net leverage ratio improved to 4.2x (down ~0.5 turn from peak).
Inventory and Capital Discipline
Lowered inventory levels by $26 million versus 2024 while supporting full-year organic sales growth; reduced annual capital expenditures by $15 million in 2025 (CapEx $40 million), with disciplined increase to $45 million planned in 2026 focused 50/50 on growth and efficiency.
Safety and Cultural Transformation
Company-wide safety metrics improved by almost 10%; management described a company-wide cultural transformation prioritizing agility, commercial excellence and accountability.
SAS Profitability Improvement Despite Volume Pressure
SAS Q4 adjusted EBITDA nearly $39 million, up >8% YoY, with margins improving to 13.6% (up 130 basis points), reflecting lower manufacturing costs and favorable price-to-input-cost dynamics even as organic volumes were flat or down in pockets.
Negative Updates
SAS Volume Weakness and European Pressure
SAS experienced lower-than-expected volumes in labels, automotive tapes and release liners (particularly in Europe). Q4 SAS net sales of $285 million were largely flat organically and down roughly $5 million reported versus prior year.
Soft Demand and Volume Risk Into 2026
Management expects anemic end-market demand to persist into Q1 2026; top-line volume growth forecasted to be low single-digit in early 2026, which could pressure operating leverage and growth cadence.
Raw Material Cost Headwind Forecast
Management expects a $20–$25 million headwind in raw material costs in 2026 (resins, polymers, pulp and paper), weighted toward the second half of the year, requiring pricing actions to offset.
Leverage Remains Elevated
Net debt of $934 million and net leverage of 4.2x remain above management's target range (2.5–3.5x), indicating continued focus needed on deleveraging despite progress.
Higher Distribution and Manufacturing Costs
Q4 results were partially offset by increased distribution costs (cross-sourcing due to tariffs) and certain higher manufacturing costs; unfavorable volume mix also reduced some benefits from pricing.
One-Time and Recurring Cash Outlays Expected in 2026
Planned 2026 headwinds include one-time cash costs of $5–$10 million to fund savings initiatives, a $10 million net working capital investment, ~$74 million estimated interest expense, and $8 million in annual fees for an accounts receivable securitization facility.
Other Income Turned to Expense
Other expense in Q4 was roughly $3 million versus other income of approximately $9 million in 2024, driven by prior-year asset sale gains and favorable FX — a negative swing to current-year profitability.
Timing of New Growth Projects
Strategic collaborations (e.g., partnership with Miru) are expected to contribute revenue more meaningfully in late 2026 or 2027, limiting near-term upside from new initiatives.
Company Guidance
The company guided to Q1 2026 adjusted EBITDA growth of roughly 15%–20% year‑over‑year despite soft demand and only low single‑digit volume growth, and outlined full‑year assumptions including $45 million of capital expenditures (about 50/50 growth vs. efficiency), $15–20 million of incremental Wave 2 cost savings, $5–10 million of one‑time cash costs to fund savings, a $10 million working‑capital investment, combined depreciation/amortization/stock‑based comp of ~$90 million, interest expense of roughly $74 million, and $8 million of annual fees for the A/R securitization facility; management also expects a $20–25 million raw‑material cost headwind (weighted to H2), anticipates free cash flow modestly below 2025’s record $94 million to fund growth, and plans to make further progress toward a target net‑leverage range of 2.5–3.5x (expecting to finish 2026 in the mid‑to‑high 3s).

Mativ Holdings Financial Statement Overview

Summary
Revenue has grown strongly into 2025, but results are dominated by sharply deteriorated profitability (deep 2025 net loss and negative EBITDA) and elevated leverage (higher debt-to-equity and very negative ROE). Positive and improving operating/free cash flow provides some cushion, but debt remains high versus the earnings profile.
Income Statement
26
Negative
Revenue has grown materially from 2020 ($1.07B) to 2025 ($1.99B), including +22.7% in 2025, but profitability has deteriorated sharply. After modest losses in 2022–2024, 2025 swung to a deep net loss (-$337M) and negative EBITDA (-$384M), with net margin at -17.0%. Gross margin has been relatively steady (~18–20% recently), suggesting the main pressure is below gross profit (cost structure/charges), creating a weak earnings quality profile and volatile results.
Balance Sheet
30
Negative
Leverage is elevated and worsened in 2025: debt-to-equity rose to ~2.15x (from ~1.34x in 2024) as equity declined to $499M. Returns to shareholders are strongly negative (return on equity -67.7% in 2025), reflecting sizable losses against a thinner equity base. Total debt remains high at ~$1.07B, which limits flexibility if earnings remain pressured, although total assets are still sizable (~$2.05B).
Cash Flow
55
Neutral
Cash generation is a relative bright spot: operating cash flow was positive across the period and improved to $134M in 2025 (up from $95M in 2024), with free cash flow also $134M in 2025 and showing strong growth versus the prior year. That said, cash flow coverage of debt remains modest (operating cash flow covering ~47% of total debt in 2025), and the business has shown volatility (e.g., free cash flow fell materially in 2023 before rebounding).
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.99B1.98B2.03B1.64B930.70M
Gross Profit299.70M364.10M355.80M306.00M183.20M
EBITDA-249.50M139.60M-270.90M70.70M81.00M
Net Income-337.40M-48.70M-309.50M-6.60M88.90M
Balance Sheet
Total Assets2.05B2.45B2.64B3.67B2.42B
Cash, Cash Equivalents and Short-Term Investments84.20M94.30M120.20M101.10M74.70M
Total Debt1.12B1.15B1.17B1.74B1.30B
Total Liabilities1.55B1.59B1.69B2.49B1.74B
Stockholders Equity498.70M858.50M949.10M1.18B682.20M
Cash Flow
Free Cash Flow93.80M39.20M40.20M142.60M19.20M
Operating Cash Flow133.80M94.80M106.60M202.20M58.10M
Investing Cash Flow-37.00M-56.70M547.20M-481.30M-636.50M
Financing Cash Flow-106.70M-55.90M-662.90M331.60M599.90M

Mativ Holdings Technical Analysis

Technical Analysis Sentiment
Negative
Last Price13.31
Price Trends
50DMA
11.92
Negative
100DMA
11.91
Negative
200DMA
10.51
Negative
Market Momentum
MACD
-1.05
Positive
RSI
22.67
Positive
STOCH
4.89
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MATV, the sentiment is Negative. The current price of 13.31 is above the 20-day moving average (MA) of 10.23, above the 50-day MA of 11.92, and above the 200-day MA of 10.51, indicating a bearish trend. The MACD of -1.05 indicates Positive momentum. The RSI at 22.67 is Positive, neither overbought nor oversold. The STOCH value of 4.89 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MATV.

Mativ Holdings Risk Analysis

Mativ Holdings disclosed 32 risk factors in its most recent earnings report. Mativ Holdings reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Mativ Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
$5.13B18.579.23%1.53%-3.90%-25.97%
67
Neutral
$12.80B4.8131.48%1.96%6.65%47.88%
64
Neutral
$5.38B38.728.46%1.37%-3.26%-46.80%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
52
Neutral
$474.37M-1.97-77.52%3.26%0.39%-505.56%
44
Neutral
$213.79M1.93-2.50%-21.76%-1214.73%
44
Neutral
$96.45M-0.27-151.86%10.77%-5.85%9.13%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MATV
Mativ Holdings
8.66
2.50
40.61%
CLW
Clearwater Paper
13.33
-11.01
-45.23%
LPX
Louisiana-Pacific
77.09
-14.32
-15.66%
MERC
Mercer International
1.44
-4.75
-76.74%
UFPI
UFP Industries
90.65
-15.39
-14.52%
SUZ
Suzano Papel e Celulose SA
10.12
0.64
6.73%

Mativ Holdings Corporate Events

Executive/Board Changes
Mativ Holdings Updates CEO Compensation and Severance Terms
Neutral
Feb 11, 2026

On February 6, 2026, Mativ Holdings’ Compensation Committee approved an amendment to the March 11, 2025 offer letter for President and Chief Executive Officer Shruti Singhal, effective January 1, 2026, setting his annual base salary at $950,000 and maintaining his eligibility for an annual short-term incentive bonus based on a Board- or Committee-determined percentage of base pay. The amendment also preserves Singhal’s eligibility for long-term equity-based incentives under the company’s 2024 Equity and Incentive Plan at a Board- or Committee-set target level and formalizes the company’s severance obligations, customary employment terms, and in-term and post-term restrictive covenants, clarifying the leadership compensation framework for stakeholders.

The most recent analyst rating on (MATV) stock is a Hold with a $13.00 price target. To see the full list of analyst forecasts on Mativ Holdings stock, see the MATV Stock Forecast page.

Executive/Board ChangesRegulatory Filings and Compliance
Mativ Holdings Finalizes Separation Agreement with Former CFO
Neutral
Jan 14, 2026

Mativ Holdings, Inc. reported that its former Chief Financial Officer, Gregory Weitzel, whose departure was announced in a December 16, 2025 filing and became effective December 31, 2025, has formally entered into a separation agreement with the company as of January 8, 2026. The agreement confirms that Weitzel’s severance benefits and post-termination obligations will follow the terms of the company’s Executive Severance Plan and the governing documents for his outstanding equity awards, and that these benefits are aligned with those previously described in the company’s March 21, 2025 definitive proxy statement, providing clarity and continuity for stakeholders around the leadership transition and its financial implications.

The most recent analyst rating on (MATV) stock is a Hold with a $13.00 price target. To see the full list of analyst forecasts on Mativ Holdings stock, see the MATV Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 20, 2026